Researchers from University of Arizona present a new therapeutic target to shield nerve cells from the damage of ALS.
A newly identified experimental compound, XL20, has demonstrated neuroprotective effects in mouse models and human motor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results